21st Jan 2016 13:31
LONDON (Alliance News) - Respiratory drug development company Verona Pharma PLC said Chairman David Ebsworth bought 400,000 shares at a price of 2.5 pence each on Wednesday.
Following this transaction, Ebsworth holds 4.6 million shares, which represents 0.46% of the total voting rights.
The stock was up 9.2% at 2.59p Thursday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
VRP.L